BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 25495340)

  • 1. Are drug metabolites able to cause T-cell-mediated hypersensitivity reactions?
    Sullivan A; Gibson A; Park BK; Naisbitt DJ
    Expert Opin Drug Metab Toxicol; 2015 Mar; 11(3):357-68. PubMed ID: 25495340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactive metabolites and their role in drug reactions.
    Naisbitt DJ; Williams DP; Pirmohamed M; Kitteringham NR; Park BK
    Curr Opin Allergy Clin Immunol; 2001 Aug; 1(4):317-25. PubMed ID: 11964707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug Hypersensitivity: How Drugs Stimulate T Cells via Pharmacological Interaction with Immune Receptors.
    Pichler WJ; Adam J; Watkins S; Wuillemin N; Yun J; Yerly D
    Int Arch Allergy Immunol; 2015; 168(1):13-24. PubMed ID: 26524432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell responses to drugs and drug metabolites.
    Earnshaw CJ; Pecaric-Petkovic T; Park BK; Naisbitt DJ
    Exp Suppl; 2014; 104():137-63. PubMed ID: 24214623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of HLA-allele associations for the study of type IV drug hypersensitivity reactions.
    Sullivan A; Watkinson J; Waddington J; Park BK; Naisbitt DJ
    Expert Opin Drug Metab Toxicol; 2018 Mar; 14(3):261-274. PubMed ID: 29460640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of bioactivation in drug-induced hypersensitivity reactions.
    Sanderson JP; Naisbitt DJ; Park BK
    AAPS J; 2006 Feb; 8(1):E55-64. PubMed ID: 16584134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of reactive drug metabolites in immune-mediated adverse drug reactions.
    Hess DA; Rieder MJ
    Ann Pharmacother; 1997 Nov; 31(11):1378-87. PubMed ID: 9391694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of idiosyncratic drug reactions: reactive metabolite formation, protein binding and the regulation of the immune system.
    Ju C; Uetrecht JP
    Curr Drug Metab; 2002 Aug; 3(4):367-77. PubMed ID: 12093356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological principles of T-cell-mediated adverse drug reactions in skin.
    Naisbitt DJ; Pirmohamed M; Park BK
    Expert Opin Drug Saf; 2007 Mar; 6(2):109-24. PubMed ID: 17367257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noncovalent interactions of drugs with immune receptors may mediate drug-induced hypersensitivity reactions.
    Gerber BO; Pichler WJ
    AAPS J; 2006 Mar; 8(1):E160-5. PubMed ID: 16584124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The roles of drug metabolism in the pathogenesis of T-cell-mediated drug hypersensitivity.
    Lavergne SN; Park BK; Naisbitt DJ
    Curr Opin Allergy Clin Immunol; 2008 Aug; 8(4):299-307. PubMed ID: 18596585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular aspects of drug recognition by specific T cells.
    Britschgi M; von Greyerz S; Burkhart C; Pichler WJ
    Curr Drug Targets; 2003 Jan; 4(1):1-11. PubMed ID: 12528985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-Cell Activation by Low Molecular Weight Drugs and Factors That Influence Susceptibility to Drug Hypersensitivity.
    Hammond S; Thomson PJ; Ogese MO; Naisbitt DJ
    Chem Res Toxicol; 2020 Jan; 33(1):77-94. PubMed ID: 31687800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed drug hypersensitivity reactions - new concepts.
    Posadas SJ; Pichler WJ
    Clin Exp Allergy; 2007 Jul; 37(7):989-99. PubMed ID: 17581192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of human T cells with sulfonamides and sulfonamide metabolites.
    Castrejon JL; Berry N; El-Ghaiesh S; Gerber B; Pichler WJ; Park BK; Naisbitt DJ
    J Allergy Clin Immunol; 2010 Feb; 125(2):411-418.e4. PubMed ID: 20159253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic activation in drug allergies.
    Park BK; Naisbitt DJ; Gordon SF; Kitteringham NR; Pirmohamed M
    Toxicology; 2001 Feb; 158(1-2):11-23. PubMed ID: 11164988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deciphering the immune pathomechanism of cutaneous drug reactions.
    Pichler WJ
    Allergy; 2002; 57 Suppl 72():34-6. PubMed ID: 12144552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolomics in drug intolerance.
    Andreu I; Mayorga C; Miranda MA
    Curr Drug Metab; 2009 Nov; 10(9):947-55. PubMed ID: 20214587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological principles of adverse drug reactions: the initiation and propagation of immune responses elicited by drug treatment.
    Naisbitt DJ; Gordon SF; Pirmohamed M; Park BK
    Drug Saf; 2000 Dec; 23(6):483-507. PubMed ID: 11144658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactive Metabolites: Current and Emerging Risk and Hazard Assessments.
    Thompson RA; Isin EM; Ogese MO; Mettetal JT; Williams DP
    Chem Res Toxicol; 2016 Apr; 29(4):505-33. PubMed ID: 26735163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.